WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Releases Updated NRDL and First Commercial Insurance Innovative Drug Lis... China announced on December 7 the release of an updated National Reimbursement Drug List (NRDL) and the country's first Commercial Insurance Innovative Drug List, marking...
(12/8/2025)

China Biotech Outlicensing Surges Past US$52 B... (3/4/2026)

2026 Biotech Playbook: Hong Kong at the Centre... (3/2/2026)

China's Healthcare Reform Playbook: Boosting B... (2/26/2026)

China Outpaces US and EU in Drug R&D with Fast... (2/25/2026)

Global Pharma Giants Rush to License Chinese W... (2/25/2026)

The Patent Term Compensation and Protection Sc... (2/25/2026)

After 230% Deal Size Explosion, China Is No Lo... (2/24/2026)

China Biotech Kicks Off 2026 with $863 Million... (2/20/2026)

Long-Acting Obesity Drugs Drive Record January... (2/16/2026)

China's Innovation in Translational Medicine: ... (2/16/2026)

China Biotech Dealmaking and Financing Stay St... (2/13/2026)

China NMPA Approves Nine New Drugs in January ... (2/12/2026)

CMS Wins China Trial Approval for INHBE-... (3/5/2026) CDE Issues Guidance on Subject Selection... (3/5/2026) CSPC's Emicizumab Injection Receives Cli... (3/4/2026) CDE Invites Feedback on Draft Technical ... (3/4/2026) CDE Issues Technical Guideline on Clinic... (3/4/2026) Leman Biotech Raises ~CNY 200M to Advanc... (3/4/2026) Immunofoco Raises ~CNY 200M in Pre-IPO R... (3/4/2026) Minwei Biotech's siRNA Therapy MWX401 Cl... (3/4/2026) Antengene Strikes $1.1B+ CD19 T-Cell Eng... (3/4/2026) Sanofi Licenses Sino Biopharm's Transpla... (3/4/2026) Eli Lilly Advances New Oral Diabetes The... (3/4/2026) LongBio Pharma's LP‑003 Shows Superior ... (3/3/2026) Clickmab Biotech Secures Seed+ Funding t... (3/3/2026) Rallybio to Merge with Candid Therapeuti... (3/3/2026) Prolium Launches with $50M to Advance Ch... (3/3/2026) China Approves Five NMEs in February as ... (3/3/2026) China Approves Jaypirca for Expanded Blo... (3/2/2026) CDE Issues Interim Guidelines for Synth... (3/2/2026)

China Pharmaceutical Market Projected to Reach US$573B ... China's Vaccine Exports Jump More Than 50% in 2025 as O... China's Vaccine Market Set for Slow but Steady Growth T... China Companion Animal Health Market to Reach US$ 3.7B ... China's Pet Obesity Sparks Biotech Race for Weight-Loss...

Sanofi Licenses Sino Biopharm's Transplant Therapy in $... Antengene Strikes $1.1B+ CD19 T-Cell Engager Deal with ... Immunofoco Raises ~CNY 200M in Pre-IPO Round Ahead of H... Leman Biotech Raises ~CNY 200M to Advance Metabolism-En... Prolium Launches with $50M to Advance China-Licensed T-...

CDE Issues Guidance on Subject Selection for Oncology D... CDE Issues Technical Guideline on Clinical Trials for D... CDE Invites Feedback on Draft Technical Guideline for P... CDE Issues Interim Guidelines for Synthetic Oligonucle... CDE Solicits Comments on Batch 104 of Chemical Generic ...

China's Tech Giants Pour Billions Into AI Healthcare Am... China-SCO Cooperation Center for Metabolic Diseases Lau... China Accelerates Dementia Research to Challenge U.S. L... China Expands Mutual Recognition of Medical Tests to St... NHSA Issues Trial Measures for Early Communication on R...

U.S. ITC to Probe China's Trade Status and Biotech Prac... China Schedules Antitrust Hearing in Abuse‑of‑Dominan... Pentagon Reverses Decision After Briefly Listing WuXi A... China Indicts AstraZeneca and Former China Head Leon Wa... Roche and Henlius–Organon Resolve U.S. Patent Dispute ...

Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk See... Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac... Clariant Completes Expansion of Pharma Excipients and S...

CMS Wins China Trial Approval for INHBE-Targeting Obesi... Eli Lilly Advances New Oral Diabetes Therapy in China Minwei Biotech's siRNA Therapy MWX401 Cleared for Clini... CSPC's Emicizumab Injection Receives Clinical Trial App... China Approves Five NMEs in February as Innovation Expa...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...